WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the appointment of James M. Mock to senior vice president and chief financial officer (CFO), effective May 1, 2018. Andy Wilson, PerkinElmer’s current senior vice president and CFO, who previously announced his retirement from PerkinElmer, will remain with the Company as an advisor for an interim period of time to ensure a smooth transition and integration for Mr. Mock.
“I am excited to welcome Jamey to PerkinElmer and look forward to his contributions, as he brings extensive experience overseeing the financial and commercial management of leading global organizations,” said Robert F. Friel, PerkinElmer’s president and chief executive officer. “Jamey’s financial leadership capabilities are an ideal complement to our focus on driving PerkinElmer to its next phase of growth and profitability.”
Mr. Mock joins PerkinElmer after serving for nearly 20 years in a wide range of financial oversight capacities within General Electric Company (GE). He was most recently vice president, Corporate Audit Staff, where he worked globally across GE’s businesses on controllership reviews and operational excellence projects. Prior to that, he served in a number of progressively responsible leadership roles in multifaceted global businesses based in the United States and overseas.
About PerkinElmer
PerkinElmer, Inc. is a global leader
focused on innovating for a healthier world. The Company reported
revenue of approximately $2.3 billion in 2017, has about 11,000
employees serving customers in more than 150 countries, and is a
component of the S&P 500 Index. Additional information is available
through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Factors Affecting Future Performance
This press release
contains "forward-looking" statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including, but not limited to,
statements relating to estimates and projections of future earnings per
share, cash flow and revenue growth and other financial results,
developments relating to our customers and end-markets, and plans
concerning business development opportunities, acquisitions and
divestitures. Words such as "believes," "intends," "anticipates,"
"plans," "expects," "projects," "forecasts," "will" and similar
expressions, and references to guidance, are intended to identify
forward-looking statements. Such statements are based on management's
current assumptions and expectations and no assurances can be given that
our assumptions or expectations will prove to be correct. A number of
important risk factors could cause actual results to differ materially
from the results described, implied or projected in any forward-looking
statements. These factors include, without limitation: (1) markets into
which we sell our products declining or not growing as anticipated; (2)
fluctuations in the global economic and political environments; (3) our
failure to introduce new products in a timely manner; (4) our ability to
execute acquisitions and license technologies, or to successfully
integrate acquired businesses such as EUROIMMUN and licensed
technologies into our existing business or to make them profitable, or
successfully divest businesses; (5) our failure to adequately protect
our intellectual property; (6) the loss of any of our licenses or
licensed rights; (7) our ability to compete effectively; (8) fluctuation
in our quarterly operating results and our ability to adjust our
operations to address unexpected changes; (9) significant disruption in
third-party package delivery and import/export services or significant
increases in prices for those services; (10) disruptions in the supply
of raw materials and supplies; (11) the manufacture and sale of products
exposing us to product liability claims; (12) our failure to maintain
compliance with applicable government regulations; (13) regulatory
changes; (14) our failure to comply with healthcare industry
regulations; (15) economic, political and other risks associated with
foreign operations; (16) our ability to retain key personnel; (17)
significant disruption in our information technology systems; (18) our
ability to obtain future financing; (19) restrictions in our credit
agreements; (20) the United Kingdom’s intention to withdraw from the
European Union; (21) our ability to realize the full value of our
intangible assets; (22) significant fluctuations in our stock price;
(23) reduction or elimination of dividends on our common stock; and (24)
other factors which we describe under the caption "Risk Factors" in our
most recent annual report on Form 10-K and in our other filings with the
Securities and Exchange Commission. We disclaim any intention or
obligation to update any forward-looking statements as a result of
developments occurring after the date of this press release.
